Covaxin’s Phase 2/3 trials in US put on hold

Hyderabad, April 14: The phase 2/3 clinical trials of Bharat Biotech’s COVID-19 vaccine Covaxin have been put on hold in the US by the Food and Drug Administration.The FDA’s decision was based on the US firm’s decision to voluntarily implement

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News